Immuron Limited Stock: price and insider trades · Australia
Immuron Limited: what insiders have been doing
Immuron Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. 1 insider has disclosed 4 filings since 27 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought Immuron Limited shares on the open market in the past twelve months.
Across the 1,602 companies tracked on its exchange, the median is 5 filings; at 4 filings, this issuer sits below that mark.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from ASX. Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXASX:2924-03142835-3A703033
- ShareASXISIN AU000000IMC7ASX:2924-03111473-3A697228
- ShareASXASX:2924-03105941-3A696306
- ShareASXISIN AU000000IMC7ASX:2924-03096522-3A694592
4 of 4 declarations
About Immuron Limited
Immuron Limited is an Australian Securities Exchange listed company focused on developing treatments for intestinal diseases. The company emphasizes research and innovation in the healthcare sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
